OPTI SARS-CoV-2 RNA PCR Test Kit receives US FDA Emergency Use Authorization
|The test kit is based on real-time reverse transcription polymerase chain reaction (RT-PCR), which provides detection of the viral RNA in the sample. The OPTI SARS-CoV-2 RT-PCR test kit detects human RNase P as an internal sample control and endogenous nucleic acid to control for sample addition, extraction and amplification. The test provides results in approximately 2–3.5 hours and has been validated on commonly available qPCR instruments.|
Producer of Blood Gas and Electrolyte Analyzers
OPTI Medical Systems, Inc. is an innovative leader in the design and manufacturing of near-patient, clinical diagnostics equipment. We have a reputation for leveraging advanced diagnostic technologies to develop highly reliable, cost-effective products that combine high accuracy with exceptional convenience, ease of use and clinical flexibility. We pride ourselves in our attention to customers' needs, providing many routes of communication and collaboration.
COVID-19 test kit availability
No phone calls
IDEXX Investor Resources
Portable analyzers for the measurement of time-sensitive diagnostic tests wherever time-critical diagnostic testing is needed.
Add value to your OPTI® analyzers. Join the Online Quality Assurance Program (QAP), which facilitates the evaluation of quality control (QC) data with that of your peers for trends and shifts.